The consistent elevated expression of KLF4 in the explants examined combined with its expression in LNG-resistant endometrial cancer cell lines and primary cells [21] provides evidence for KLF4 as a potential biomarker for LNG resistance, and further investigation of this protein in a larger patient cohort is warranted. Here, KLF4 is linked to endometrial cancer.